Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
immunology
Fierce Pharma
Obesity meds, China drive $2T in projected 2032 drug sales: report
Together, drugs tackling obesity and inflammatory conditions are expected to push global pharmaceutical sales above $2 trillion in 2032, per Evaluate.
Fraiser Kansteiner
Jun 23, 2026 9:00am
Biogen inks $1B RayThera buyout to bag immunology assets
Jun 18, 2026 4:10am
Gilead scraps lead arthritis drug from $405M MiroBio buyout
May 29, 2026 7:18am
BMS inks $15B deal to bag Hengrui assets, tap China’s R&D speed
May 12, 2026 1:56am
Biogen inks $850M deal with TJ for China rights antibody
Apr 20, 2026 10:26am
Odyssey charts new voyage to Nasdaq after false start last year
Apr 20, 2026 7:19am